Selected research
Industry Research
Hog Cholera Vaccine Industry Research Report 2026
Market perspective
The global Hog Cholera Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hog Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hog Cholera Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hog Cholera Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hog Cholera Vaccine include WINSUN, Agrovet, Bioveta, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, Chopper Biology and DHN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hog Cholera Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hog Cholera Vaccine Market by Company
WINSUN
Agrovet
Bioveta
Boehringer Ingelheim
CAHIC
CAVAC
Ceva
Chopper Biology
DHN
Institutul Pasteur
Komipharm
MSD Animal Health (Merck)
MVP
Ringpu Biology
Tecon
ChengDu Tecbond
Jinyu Bio-Technology
Qilu Animal Health Products Factory
Harbin Veterinary Research Institute
Hog Cholera Vaccine Segment by Type
Tissue Culture Origin
Cell Line Origin
Hog Cholera Vaccine Segment by Application
Government Tender
Market Sales
Hog Cholera Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hog Cholera Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hog Cholera Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hog Cholera Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hog Cholera Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hog Cholera Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hog Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tissue Culture Origin
- Cell Line Origin
Applications
- Government Tender
- Market Sales
Companies covered
- WINSUN
- Agrovet
- Bioveta
- Boehringer Ingelheim
- CAHIC
- CAVAC
- Ceva
- Chopper Biology
- DHN
- Institutul Pasteur
- Komipharm
- MSD Animal Health (Merck)
- MVP
- Ringpu Biology
- Tecon
- ChengDu Tecbond
- Jinyu Bio-Technology
- Qilu Animal Health Products Factory
- Harbin Veterinary Research Institute
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hog Cholera Vaccine Market Size (2021-2032)
- 2.2.2 Global Hog Cholera Vaccine Sales (2021-2032)
- 2.2.3 Global Hog Cholera Vaccine Market Average Price (2021-2032)
- 2.3 Hog Cholera Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tissue Culture Origin
- 2.3.3 Cell Line Origin
- 2.4 Hog Cholera Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Government Tender
- 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hog Cholera Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hog Cholera Vaccine Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Hog Cholera Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Hog Cholera Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Hog Cholera Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hog Cholera Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hog Cholera Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Hog Cholera Vaccine, Established Date
- 3.9 Global Hog Cholera Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 WINSUN
- 4.1.1 WINSUN Company Information
- 4.1.2 WINSUN Business Overview
- 4.1.3 WINSUN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 WINSUN Hog Cholera Vaccine Product Portfolio
- 4.1.5 WINSUN Recent Developments
- 4.2 Agrovet
- 4.2.1 Agrovet Company Information
- 4.2.2 Agrovet Business Overview
- 4.2.3 Agrovet Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Agrovet Hog Cholera Vaccine Product Portfolio
- 4.2.5 Agrovet Recent Developments
- 4.3 Bioveta
- 4.3.1 Bioveta Company Information
- 4.3.2 Bioveta Business Overview
- 4.3.3 Bioveta Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bioveta Hog Cholera Vaccine Product Portfolio
- 4.3.5 Bioveta Recent Developments
- 4.4 Boehringer Ingelheim
- 4.4.1 Boehringer Ingelheim Company Information
- 4.4.2 Boehringer Ingelheim Business Overview
- 4.4.3 Boehringer Ingelheim Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boehringer Ingelheim Hog Cholera Vaccine Product Portfolio
- 4.4.5 Boehringer Ingelheim Recent Developments
- 4.5 CAHIC
- 4.5.1 CAHIC Company Information
- 4.5.2 CAHIC Business Overview
- 4.5.3 CAHIC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CAHIC Hog Cholera Vaccine Product Portfolio
- 4.5.5 CAHIC Recent Developments
- 4.6 CAVAC
- 4.6.1 CAVAC Company Information
- 4.6.2 CAVAC Business Overview
- 4.6.3 CAVAC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CAVAC Hog Cholera Vaccine Product Portfolio
- 4.6.5 CAVAC Recent Developments
- 4.7 Ceva
- 4.7.1 Ceva Company Information
- 4.7.2 Ceva Business Overview
- 4.7.3 Ceva Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ceva Hog Cholera Vaccine Product Portfolio
- 4.7.5 Ceva Recent Developments
- 4.8 Chopper Biology
- 4.8.1 Chopper Biology Company Information
- 4.8.2 Chopper Biology Business Overview
- 4.8.3 Chopper Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chopper Biology Hog Cholera Vaccine Product Portfolio
- 4.8.5 Chopper Biology Recent Developments
- 4.9 DHN
- 4.9.1 DHN Company Information
- 4.9.2 DHN Business Overview
- 4.9.3 DHN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 DHN Hog Cholera Vaccine Product Portfolio
- 4.9.5 DHN Recent Developments
- 4.10 Institutul Pasteur
- 4.10.1 Institutul Pasteur Company Information
- 4.10.2 Institutul Pasteur Business Overview
- 4.10.3 Institutul Pasteur Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Institutul Pasteur Hog Cholera Vaccine Product Portfolio
- 4.10.5 Institutul Pasteur Recent Developments
- 4.11 Komipharm
- 4.11.1 Komipharm Company Information
- 4.11.2 Komipharm Business Overview
- 4.11.3 Komipharm Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Komipharm Hog Cholera Vaccine Product Portfolio
- 4.11.5 Komipharm Recent Developments
- 4.12 MSD Animal Health (Merck)
- 4.12.1 MSD Animal Health (Merck) Company Information
- 4.12.2 MSD Animal Health (Merck) Business Overview
- 4.12.3 MSD Animal Health (Merck) Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 MSD Animal Health (Merck) Hog Cholera Vaccine Product Portfolio
- 4.12.5 MSD Animal Health (Merck) Recent Developments
- 4.13 MVP
- 4.13.1 MVP Company Information
- 4.13.2 MVP Business Overview
- 4.13.3 MVP Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 MVP Hog Cholera Vaccine Product Portfolio
- 4.13.5 MVP Recent Developments
- 4.14 Ringpu Biology
- 4.14.1 Ringpu Biology Company Information
- 4.14.2 Ringpu Biology Business Overview
- 4.14.3 Ringpu Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Ringpu Biology Hog Cholera Vaccine Product Portfolio
- 4.14.5 Ringpu Biology Recent Developments
- 4.15 Tecon
- 4.15.1 Tecon Company Information
- 4.15.2 Tecon Business Overview
- 4.15.3 Tecon Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Tecon Hog Cholera Vaccine Product Portfolio
- 4.15.5 Tecon Recent Developments
- 4.16 ChengDu Tecbond
- 4.16.1 ChengDu Tecbond Company Information
- 4.16.2 ChengDu Tecbond Business Overview
- 4.16.3 ChengDu Tecbond Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 ChengDu Tecbond Hog Cholera Vaccine Product Portfolio
- 4.16.5 ChengDu Tecbond Recent Developments
- 4.17 Jinyu Bio-Technology
- 4.17.1 Jinyu Bio-Technology Company Information
- 4.17.2 Jinyu Bio-Technology Business Overview
- 4.17.3 Jinyu Bio-Technology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Jinyu Bio-Technology Hog Cholera Vaccine Product Portfolio
- 4.17.5 Jinyu Bio-Technology Recent Developments
- 4.18 Qilu Animal Health Products Factory
- 4.18.1 Qilu Animal Health Products Factory Company Information
- 4.18.2 Qilu Animal Health Products Factory Business Overview
- 4.18.3 Qilu Animal Health Products Factory Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Qilu Animal Health Products Factory Hog Cholera Vaccine Product Portfolio
- 4.18.5 Qilu Animal Health Products Factory Recent Developments
- 4.19 Harbin Veterinary Research Institute
- 4.19.1 Harbin Veterinary Research Institute Company Information
- 4.19.2 Harbin Veterinary Research Institute Business Overview
- 4.19.3 Harbin Veterinary Research Institute Hog Cholera Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Harbin Veterinary Research Institute Hog Cholera Vaccine Product Portfolio
- 4.19.5 Harbin Veterinary Research Institute Recent Developments
5 Global Hog Cholera Vaccine Market Scenario by Region
- 5.1 Global Hog Cholera Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hog Cholera Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Hog Cholera Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Hog Cholera Vaccine Sales by Region: 2027-2032
- 5.3 Global Hog Cholera Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Hog Cholera Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Hog Cholera Vaccine Revenue by Region: 2027-2032
- 5.4 North America Hog Cholera Vaccine Market Facts & Figures by Country
- 5.4.1 North America Hog Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hog Cholera Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Hog Cholera Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hog Cholera Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Hog Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hog Cholera Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Hog Cholera Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hog Cholera Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hog Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hog Cholera Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hog Cholera Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hog Cholera Vaccine Market Facts & Figures by Country
- 5.7.1 South America Hog Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hog Cholera Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Hog Cholera Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hog Cholera Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hog Cholera Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hog Cholera Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hog Cholera Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hog Cholera Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Hog Cholera Vaccine Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Hog Cholera Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Hog Cholera Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Hog Cholera Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hog Cholera Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Hog Cholera Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hog Cholera Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Hog Cholera Vaccine Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Hog Cholera Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Hog Cholera Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Hog Cholera Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hog Cholera Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Hog Cholera Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hog Cholera Vaccine Value Chain Analysis
- 8.1.1 Hog Cholera Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hog Cholera Vaccine Production Mode & Process
- 8.2 Hog Cholera Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hog Cholera Vaccine Distributors
- 8.2.3 Hog Cholera Vaccine Customers
9 Global Hog Cholera Vaccine Analyzing Market Dynamics
- 9.1 Hog Cholera Vaccine Industry Trends
- 9.2 Hog Cholera Vaccine Industry Drivers
- 9.3 Hog Cholera Vaccine Industry Opportunities and Challenges
- 9.4 Hog Cholera Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst